LONDRES, GBR. La mayoría de los pacientes hospitalizados con infecciones virales agudas reciben antibióticos como precaución contra la coinfección bacteriana, pero esta práctica podría no mejorar la sobrevida, sugiere una nueva investigación. Los investigadores evaluaron el impacto del uso de antibióticos en la sobrevida de más de 2.100 pacientes en […]
Read More
Infectólogo insiste en la necesidad de implementar, nuevamente, las medidas de bioseguridad en escuelas tras darse a conocer el nuevo virus que circula en Puerto Rico. En medio de lo que algunos científicos han bautizado como tri epidemia, un nuevo síndrome viral que puede presentar síntomas más fuertes que el […]
Read More
A small study of deceased nonvaccinated men who died of COVID-19 complications suggests the testes may be a sanctuary for the SARS-CoV-2 virus, raising questions about potential consequences for reproductive health among those infected. The study, published online Tuesday on the preprint server MedRxiv, found that “patients who become critically ill exhibit severe […]
Read More
A small study of deceased nonvaccinated men who died of COVID-19 complications suggests the testes may be a sanctuary for the SARS-CoV-2 virus, raising questions about potential consequences for reproductive health among those infected. The study, published online Tuesday on the preprint server MedRxiv, found that “patients who become critically ill exhibit severe […]
Read More
Patients with the omicron variant of covid-19 shed virus for longer after symptoms emerge, show data from Japan, potentially jeopardising hopes that the period of isolation for people testing positive could be shortened. Preliminary data from the National Institute of Infectious Diseases—which conducts disease surveillance in Japan—suggest that the amount […]
Read More
The final week of February 2021 set two contrasting milestones in the COVID-19 pandemic. The week began mourning the more than 500,000 lives lost in this country so far in the pandemic. It ended with hope: a third COVID-19 vaccine, using a new technology platform. Introducing Janssen’s new viral vector vaccine, awarded the […]
Read More
The final week of February 2021 set two contrasting milestones in the COVID-19 pandemic. The week began mourning the more than 500,000 lives lost in this country so far in the pandemic. It ended with hope: a third COVID-19 vaccine, using a new technology platform. Introducing Janssen’s new viral vector vaccine, awarded the […]
Read More